Anavex Life Sciences Corp (AVXL)

[tredenwater2]

Hey Nidan how about this for Dr. Misslings recent purchases, all with Biogen of course:

1) the 750 share buy is for $7.5 Billion partnership (plus royalties) for an APPROVED Alz drug .

2) the 350 share purchase is for a 3.5 Billion partnership (plus royalties) for MS (if indeed there testing is working) with an approved drug.

3) the 375 share purchase is for a 3.75 Billion partnership for PK after a successful trial with an approved drug.

4) the partnership amount for Rett Syndrome is yet to be announced in the share purchase program......stay tuned!

Let me see if we take say 8% of each of those numbers for a partnership agreement for PRIOR TO APPROVAL DRUGS with STATE OF THE ART trial designs as a down.....my number at the announcement is approx. 1.18-1.25 BILLION down (add in RS)with a total package at the end in the 14 Billion range, for just A 2-73. In a year or two if you add in all the other piggy back CNS rare diseases, insomnia, possible heart disease, possible retinal degeneration....could be QUITE impressive. Funny how BIIB has about 14 Billion in cash! They/we would triple their market cap in less than 5 years. 14 Billion (1/2 of generated revenue conservativly) X multiples (conservatively) of 7 = 100 Billion plus current 60 Billion = 160 Billion market cap for Biogen. Where we would be at that point is not even comprehensible if we were still independent.

I know I know its all preposterous day dreaming at this juncture but I concur with the article mentioned and after reading it, those numbers in a period of time, in the not to distant future......, they can be VERY REAL!

Tred